All sponsors

Tasly Pharmaceutical Group Co., Ltd

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS13
PHASE 3 / 2-39
RECRUITING8
READOUTS ≤12 MONTHS7
Open Tasly Pharmaceutical Group Co., Ltd on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Antiwei Granules
NCT06697886
P3RecruitingCommon Cold4802025-06-25
Xiang Ju Ru Pi Ning capsule
NCT06685978
P3RecruitingHyperplasia of Mammary Glands4302026-04-30
Changkang granules
NCT06753890
P3Not yet recruitingDiarrhea-predominant Irritable Boewl Syndrome5202026-11-11
Jitongning tablets
NCT06000956
P3RecruitingAnkylosing Spondylitis4082026-12-01 (+16 mo)
Low dose Jia Shen Tablet
NCT06669169
P2Not yet recruitingHeart Failure2882026-12-31
Lianxiaxiaopi Granules
NCT06696261
P3RecruitingPostprandial Distress Syndrome3422026-12-31 (+7 mo)
JS1-1-01 low-dose group
NCT07485595
P2/3Not yet recruitingDepression1802026-12-31
Mesenchymal stem cells(HucMSCs)
NCT07265349
P1/2RecruitingCoronary Artery Bypass Grafting (CABG); Chronic Heart Failure512026-12-31
Susu Xiao'er Zhike Granules
NCT06773117
P3Not yet recruitingCough3602027-05-31 (+14 mo)
B2065
NCT07371624
P1/2RecruitingAcute Ischemic Stroke542027-12
P134 cell injection
NCT07318818
P1/2RecruitingRecurrent Glioblastoma IDH Wildtype262028-02-29
Qishen Yiqi Dripping Pills 2 bags
NCT07687186
P3RecruitingHeart Failure6362028-06-22
NCT07269769
NCT07269769
P3Not yet recruitingAMD4502031-12-31